SeaCrest Wealth Management’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$508K Sell
1,428
-385
-21% -$124K 0.06% 276
2026
Q2
$876K Buy
+1,813
New +$481K 0.1% 180
2026
Q1
– Sell
-1,867
Closed -$309K – 679
2025
Q4
$309K Sell
1,867
-1,114
-37% -$186K 0.03% 454
2025
Q3
$654K Buy
+2,981
New +$490K 0.07% 259
2025
Q1
– Sell
-5,211
Closed -$690K – 700
2024
Q4
$690K Buy
+5,211
New +$489K 0.07% 258

Other funds holding ALAB

SeaCrest Wealth Management's ALAB Position: Q3 2026 in Review

SeaCrest Wealth Management reduced its Astera Labs (ALAB) stake by 21% in Q3 2026, selling an estimated $124K and leaving 1,428 shares worth $508K. The position accounts for 0.06% of the portfolio, ranked #276.

SeaCrest Wealth Management first reported a position in ALAB in Q4 2024 and has held it in 5 quarters since. The position peaked at $876K in Q2 2026. 175 funds tracked by Wall St. Rank hold ALAB as of Q3 2026.

  • SeaCrest Wealth Management held 1,428 shares of Astera Labs worth $508K as of Q3 2026.
  • SeaCrest Wealth Management sold 385 Astera Labs shares in Q3 2026, an estimated $124K.
  • Astera Labs made up 0.06% of SeaCrest Wealth Management's portfolio in Q3 2026, its #276 holding.
  • SeaCrest Wealth Management first reported a position in Astera Labs in Q4 2024 and has held it in 5 quarters since.
  • SeaCrest Wealth Management's Astera Labs position peaked at $876K in Q2 2026.
  • 175 funds tracked by Wall St. Rank held Astera Labs as of Q3 2026.

Based on SeaCrest Wealth Management's 13F filing for Q3 2026, filed 21 Oct 2026.